Effects of combination of alkalization therapy plus intravenous vitamin C treatment on chemotherapy outcomes in small cell lung cancer, retrospective study

Effects of combination of alkalization therapy plus intravenous vitamin C treatment on chemotherapy outcomes in small cell lung cancer, retrospective study - Alkalization therapy plus vitamin C with chemotherapy in small cell lung cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043056

Enrollment

Registered

2021-01-19

Start date

2021-01-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with small cell lung cancer who were treated at Karasuma Wada Clinic between January 2011 and December 2018. Patients who received alkalization therapy plus intravenous vitamin C treatment. Patients who agreed informed consent.

Exclusion criteria

Exclusion criteria: Patients who could not follow the alkalization therapy and/or intravenous vitamin C treatment.

Design outcomes

Primary

Measure	Time frame
Overall survival (OS) from diagnosis Urine pH after alkalization therapy plus intravenous vitamin C treatment	—

Countries

Japan

Contacts

Public ContactReo Hamaguchi

Japanese Society on Inflammation and Metabolism in Cancer Japanese Society on Inflammation and Metabolism in Cancer, working group

reo-h@nifty.com+81-75-223-3223

Outcome results